News

There’s a very specific thrill in swapping out your clunky old rucksack for a sleek, streamlined fastpack that seems to disappear once you put it on, and that’s exactly what Gossamer Gear ...
Gossamer Gear aims the new Type II pack line to continue the brand's ethos of light and fast, ... we can’t blame Gossamer Gear for drawing on Type II fun. The Best Ultralight Tents of 2025.
A young lad dressed in a cap and pointed slippers sits hunched over a sheet of paper at work on a drawing. Beside him a dog is curled up fast asleep. This is the down-to-earth subject of a 15th ...
SAN DIEGO, May 12, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...
View Virgil Ross - Bugs Bunny and Gossamer Drawing Warner Brothers, c. 1990s by Virgil Ross on artnet. Browse upcoming and past auction lots by Virgil Ross. Price Database. 26 December 2024. Artists.
View Virgil Ross - Marvin Martian and Gossamer Drawing Warner Brothers, c. 1990s by Virgil Ross on artnet. Browse upcoming and past auction lots by Virgil Ross.
Gossamer Bio's seralutinib shows promise for PAH and PH-ILD. Click here to read what positions GOSS stock as a strong contender in the biopharmaceutical market.
Gossamer Bio has sold rights to an experimental drug that could rival a new medicine from Merck & Co., in a deal at least one analyst believes “bodes well” for the company. On Monday, Gossamer ...
Shares of Gossamer Bio Inc. plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase 2 ...
Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results - Call will be held on Tuesday, July 25 th beginning at 10 a.m. EDT - July 24 ...
Gossamer Bio said Tuesday that its experimental drug for pulmonary arterial hypertension achieved the main goal of a mid-stage clinical trial. But the treatment effect was smaller than expected ...